title: A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.
authors.affiliation: Medical Oncology Unit, Institute for Cancer Research and Treatment, Turin, Italy. giovanni.grignani@ircc.it
authors.forename: Giovanni
authors.initials: G
authors.lastname: Grignani
authors.forename: Emanuela
authors.initials: E
authors.lastname: Palmerini
authors.forename: Silvia
authors.initials: S
authors.lastname: Stacchiotti
authors.forename: Antonella
authors.initials: A
authors.lastname: Boglione
authors.forename: Virginia
authors.initials: V
authors.lastname: Ferraresi
authors.forename: Sergio
authors.initials: S
authors.lastname: Frustaci
authors.forename: Alessandro
authors.initials: A
authors.lastname: Comandone
authors.forename: Paolo G
authors.initials: PG
authors.lastname: Casali
authors.forename: Stefano
authors.initials: S
authors.lastname: Ferrari
authors.forename: Massimo
authors.initials: M
authors.lastname: Aglietta